<DOC>
	<DOCNO>NCT00089843</DOCNO>
	<brief_summary>Women Anorexia Nervosa find low bone density . The study determine whether administration low dose natural hormone , testosterone and/or risedronate , medication help prevent bone breakdown improve prevent bone loss condition .</brief_summary>
	<brief_title>Bone Loss Women With Anorexia Nervosa</brief_title>
	<detailed_description>II . SPECIFIC AIMS Severe osteopenia prevalent complication anorexia nervosa ( AN ) , affect half woman disease . Loss 25-50 % total bone mass occur frequently often permanent . Although anorexia nervosa affect 0.5-1.0 % college age woman , successful therapeutic intervention develop osteoporosis population . Bone loss anorexia nervosa characterize reduced bone formation couple increase bone resorption . Anorexia nervosa result deficiency testosterone . Testosterone administration reduces bone resorption data suggest low-dose testosterone replacement therapy increase surrogate marker bone formation . Bisphosphonates well establish decrease bone resorption improve bone density severely osteopenic postmenopausal woman . However , data regard use antiresorptive therapy woman severe pre-menopausal bone loss . Our preliminary data demonstrate administration bisphosphonate decrease bone resorption increase bone mass woman AN 6 9 month . These first data demonstrate striking increase bone density woman . We test hypothesis combine strategy increase bone formation decrease bone resorption combine testosterone bisphosphonate increase bone mass anorexia nervosa . The following hypothesis test : Specific Aim 1 . Testosterone , nutritionally dependent bone trophic factor , critical determinant decrease bone formation anorexia nervosa , administration physiologic testosterone increase bone formation lean body mass disease We investigate woman anorexia nervosa whether : A . Bone formation reduce association low serum testosterone B. Testosterone deficiency due combination ovarian adrenal defect result undernutrition C. Testosterone administration reverse testosterone deficiency lead acute sustain increase bone formation decrease bone resorption D. Administration physiologic testosterone replacement stimulate increase IGF-I level woman anorexia nervosa , mechanism increase bone formation bone density E. Administration physiologic testosterone replacement increase lean body mass , major determinant bone density Specific Aim 2 . Long-term ( 12 month ) physiologic testosterone administration combine bisphosphonate increase bone density dual anabolic anti-resorptive strategy We investigate woman anorexia nervosa whether : A. Physiologic testosterone administration increase bone density B . Administration bisphosphonate decrease excessive state bone resorption increase bone density C. Co-administration physiologic testosterone replacement bisphosphonate increase bone density great degree testosterone bisphosphonate alone increase bone formation decrease bone resorption</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Anorexia Nervosa , Over 18 , Female , Decreased bone density Medications increase bone density</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Eating Disorders</keyword>
	<keyword>Osteopenia</keyword>
</DOC>